Results:
In our cohort of patients, 116 (58%) were male and 84(42%) were female with mean age of 57.3 ± 9.7 years. As for major atherosclerotic risk factors, 146 patients (73%) had HTN, 90 patients (45%) were diabetics, 134 individuals (67%) had dyslipidaemia, 60 (30%) of them were smoker and 18 subjects (9%) had a positive FH (Table 1) . Among 200 patients, prevalence of RAS with any degree of stenosis was 22 (11%). Significant RAS was present in 12 patients (6%). It was unilateral in 9 patients (4.5%) and bilateral in 3(1.5%). In 168 individuals, significant CAD was present (84%). In the remaining 32 patients (16%) with either normal coronaries or insignificant CAD, two subjects (1%) had significant RAS. Significant RAS was more common in patients with three vessel CAD compared to those with single or two vessel CAD.(See Table 2 ). Patients with significant RAS were older compared to those without significant disease. Neither sex nor other atherosclerotic risk factors showed any association with significant RAS. 
Discussion:
Prevalence of RAS with different severities in this cohort of patients undergoing coronary angiography is within the range of most other studies. Our study showed no difference in patients with significant RAS compared to those with respect to major atherosclerotic risk factors except for age. This may reflect that traditional risk factors have a limited potential for predicting RAS. Dzieliñska et al 5 and Wang et al 12 were reported similar results, but considerable variability seen in many other studies. In our study, age more than 55 years was an independent predictor of RAS. In a number of studies, this issue addressed with different thresholds, in which it was more than 60 years at a minimum. 6, 9 Bearing in mind that not all patients with even severe RAS have uncontrolled HTN, renal failure or other clinical clues 1, 12 and the fact that well proven anti-atherothrombotic medications which block rennin-angiotensin system may act as a two edged sword in the presence of significant but clinically unsuspected bilateral RAS 1,3 underscores the need to step beyond traditional screening for RAS. Hemodynamically significant RAS may have several deleterious systemic effects through activating this system, which may accelerate atherogenesis and contribute to cardiovascular events. 13, 14 There was a good relationship between intra-arterial systolic and pulse pressures and RAS, which is in agreement with study of Weber-Mzell et al8 and Rihal et al. 18 In our study, systolic BP above 160-mmHg and pulse pressure in excess of 60 mmHg found to be independent predictors of significant RAS. We found significant relationships between atherosclerotic involvement of LAD, LCX, and RCA and RAS. As for number of coronaries involved, patients with three vessels CAD showed strong relationship with RAS and those with normal coronaries or insignificant CAD had a potent negative association with RAS. There was no relationship between anatomical distribution of coronary artery lesions (proximal, mid or distal portions) and RAS in a study by Danesh et al, 1 but two and 3-vessel coronary disease reported as an independent predictor of significant RAS. Although the therapeutic implications of incidentally detected RAS has been remained controversial until now it may be valuable to be aware of this condition given the progressive nature of the disease,the precautions in prescribing angiotensin antagonists and possibly the need to revascularization in appropriately selected cases. Given the considerable drawbacks of noninvasive imaging techniques 1,2,13 and safety of renal angiography 13, 16, 17 recognizing potential candidates for screening of RAS based on readily available variables at the time of cardiac catheterization is important from a practical point of view. Patients with incidental significant RAS may deserve aggressive interventional treatment.
Conclusion:
Simultaneous renal angiography at the time of coronary angiography might be justified particularly in older patients and having significant CAD.
